| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a08943cf95b7bf75fff3c69d5c3df82b |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-351 |
| filingDate |
2013-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_564877bb81fdfe70c923ccf112c96d40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b0a636a35e232d6b82fad4f34d7d71d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_adaaaf45f5d9a5643c06bdb625633ce6 |
| publicationDate |
2013-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2013138748-A1 |
| titleOfInvention |
Prevention of clostridium difficile infection in high risk patients |
| abstract |
The present invention relates to methods of preventing Clostridium difficile infection (COI) in a human subject who is at high risk of developing this infection, comprising administering to the subject an effective amount of the compounds described herein. In some embodiments, the subject is further receiving concomitant antibiotic therapy to prevent and/or treat an infection other than Clostridium. In some embodiments, the subject previously was treated for a Clostridium infection. In some embodiments, the compound of formula I prevents the Clostridium infection. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10137141-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-031756-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103275153-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103275153-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015169451-A1 |
| priorityDate |
2012-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |